Evidence map›Paper›PMID 22581395›Full record

ReviewCurrent hypertension reports2012

Antihypertensive treatment and sexual dysfunction.

Athanasios Manolis, Michael Doumas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hypertension reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Hypertension and erectile dysfunction: The role of endovascular therapy in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  10. Hypertension and Reproduction.Current hypertension reports · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Sexual functioning of men and women with severe obesity before bariatric surgery.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2017
    Observational
  17. Review
  18. Article
  19. Article
  20. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Athanasios ManolisCardiology Department, Asclepeion General Hospital, 41, Thassou Street, 16672, Athens, Greece. ajmanol@otenet.gr
Michael Doumas
General Hospital of Attica · GRHippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sexual dysfunction is frequently encountered in hypertensive patients. Available data indicates that sexual dysfunction is more frequent in treated than in untreated patients, generating the hypothesis that antihypertensive therapy might be associated with sexual dysfunction. Several lines of evidence suggest that differences between antihypertensive drugs exist regarding their effects on sexual function. Older antihypertensive drugs (diuretics, beta blockers) exert detrimental effects on erectile function whereas newer drugs (nebivolol, angiotensin receptor blockers) have neutral or even beneficial effects. Phosphodiesterase (PDE)-5 inhibitors are effective in hypertensive patients and can be safely administered even when multidrug regimes are used. Precautions need to be taken with alpha blockers or patients with uncontrolled high-risk hypertension, while co-administration with nitrates is contraindicated.

Indexed as

Adrenergic beta-AntagonistsAntihypertensive AgentsFemaleHumansHypertensionImpotence, VasculogenicMalePhosphodiesterase 5 InhibitorsRisk FactorsSexual Dysfunction, PhysiologicalAdrenergic beta-AntagonistsAntihypertensive AgentsPhosphodiesterase 5 Inhibitors

Identifiers

PMID22581395
OpenAlexW2091260940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.